CN107636011B - 特别在皮肤炎性疾病中用作药物的来自血纤蛋白原的分离的肽及其片段 - Google Patents

特别在皮肤炎性疾病中用作药物的来自血纤蛋白原的分离的肽及其片段 Download PDF

Info

Publication number
CN107636011B
CN107636011B CN201680026130.XA CN201680026130A CN107636011B CN 107636011 B CN107636011 B CN 107636011B CN 201680026130 A CN201680026130 A CN 201680026130A CN 107636011 B CN107636011 B CN 107636011B
Authority
CN
China
Prior art keywords
propionibacterium acnes
fibrinogen
ala
lys
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201680026130.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN107636011A (zh
Inventor
N·迪潘
P·格兰斯
V·卡尔韦
J·瑞恩若
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST GUSTAVE-ROUSSY
Paris Thackeray, University of
Western Dais Paris, University of
Centre National de la Recherche Scientifique CNRS
Assistance Publique Hopitaux de Paris APHP
Institut National de la Sante et de la Recherche Medicale INSERM
Sorbonne Universite
Universite Paris Cite
Original Assignee
INST GUSTAVE-ROUSSY
Centre National de la Recherche Scientifique CNRS
Universite Pierre et Marie Curie
Assistance Publique Hopitaux de Paris APHP
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris Descartes
Universite Paris Sud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST GUSTAVE-ROUSSY, Centre National de la Recherche Scientifique CNRS, Universite Pierre et Marie Curie, Assistance Publique Hopitaux de Paris APHP, Institut National de la Sante et de la Recherche Medicale INSERM, Universite Paris Descartes, Universite Paris Sud filed Critical INST GUSTAVE-ROUSSY
Publication of CN107636011A publication Critical patent/CN107636011A/zh
Application granted granted Critical
Publication of CN107636011B publication Critical patent/CN107636011B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN201680026130.XA 2015-03-20 2016-03-21 特别在皮肤炎性疾病中用作药物的来自血纤蛋白原的分离的肽及其片段 Active CN107636011B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305414.3 2015-03-20
EP15305414 2015-03-20
PCT/EP2016/056179 WO2016150926A1 (en) 2015-03-20 2016-03-21 Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases

Publications (2)

Publication Number Publication Date
CN107636011A CN107636011A (zh) 2018-01-26
CN107636011B true CN107636011B (zh) 2021-07-02

Family

ID=52807757

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680026130.XA Active CN107636011B (zh) 2015-03-20 2016-03-21 特别在皮肤炎性疾病中用作药物的来自血纤蛋白原的分离的肽及其片段

Country Status (10)

Country Link
US (1) US10323078B2 (https=)
EP (1) EP3270950B1 (https=)
JP (1) JP6840086B2 (https=)
CN (1) CN107636011B (https=)
AU (1) AU2016236297B2 (https=)
BR (1) BR112017020008A8 (https=)
CA (1) CA2979812C (https=)
DK (1) DK3270950T3 (https=)
ES (1) ES2880795T3 (https=)
WO (1) WO2016150926A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12502424B2 (en) 2023-05-05 2025-12-23 Sanofi Pasteur Inc. Compositions for use in treatment of acne
CN117304303B (zh) * 2023-07-14 2024-07-05 杭州恩和生物科技有限公司 纤连蛋白截短片段、组合物及用途

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012866A1 (en) * 1989-04-10 1990-11-01 Louisiana State University And Agricultural And Mechanical College Lytic peptides, use for growth, infection and cancer
CN1144539A (zh) * 1994-03-03 1997-03-05 酶遗传学公司 在转基因动物中生产纤维蛋白原
WO2003003988A2 (en) * 2001-07-06 2003-01-16 Oregon Health & Science University Peptides which modulate blood coagulation and methods of use thereof
CN102089322A (zh) * 2008-07-09 2011-06-08 普罗菲布瑞克斯公司 重组纤维蛋白原
JP2014505884A (ja) * 2011-02-02 2014-03-06 アカデミス ズィーケンハイス レイデン ハー．オー．デー．エン． エルユーエムセー 抗カルバミル化タンパク質抗体及び関節炎リスク
JP2014148541A (ja) * 2006-08-04 2014-08-21 Stb Ltd 創傷組織を治療するための固体包帯材の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
JP2003503425A (ja) * 1999-06-30 2003-01-28 リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 血栓性又は血栓塞栓性疾患のための診断的試験
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
CA2523358A1 (en) * 2003-04-23 2004-11-04 Hansa Medical Ab Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections
BRPI0617688A2 (pt) * 2005-10-21 2011-06-07 Hoffmann La Roche método para expressão recombinante de um polipeptìdeo
US20130280820A1 (en) * 2005-12-16 2013-10-24 Schering Corporation Biomarkers for psoriasis
EP2361930A3 (en) * 2007-03-26 2011-10-26 Dako Denmark A/S Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
CN101618211A (zh) * 2008-07-03 2010-01-06 珠海联邦制药股份有限公司 一种乙肝多肽疫苗及其应用
EP2352998A4 (en) 2008-11-07 2011-09-21 Centocor Ortho Biotech Inc MARKERS AND METHOD FOR THE STUDY AND TREATMENT OF LIGHT-SENSITIVELY LUPUS PATIENTS
EP4012714A1 (en) * 2010-03-23 2022-06-15 Iogenetics, LLC. Bioinformatic processes for determination of peptide binding

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012866A1 (en) * 1989-04-10 1990-11-01 Louisiana State University And Agricultural And Mechanical College Lytic peptides, use for growth, infection and cancer
CN1144539A (zh) * 1994-03-03 1997-03-05 酶遗传学公司 在转基因动物中生产纤维蛋白原
WO2003003988A2 (en) * 2001-07-06 2003-01-16 Oregon Health & Science University Peptides which modulate blood coagulation and methods of use thereof
JP2014148541A (ja) * 2006-08-04 2014-08-21 Stb Ltd 創傷組織を治療するための固体包帯材の製造方法
CN102089322A (zh) * 2008-07-09 2011-06-08 普罗菲布瑞克斯公司 重组纤维蛋白原
JP2014505884A (ja) * 2011-02-02 2014-03-06 アカデミス ズィーケンハイス レイデン ハー．オー．デー．エン． エルユーエムセー 抗カルバミル化タンパク質抗体及び関節炎リスク

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
beta-fibrinogen, partial [Homo sapiens];Chung 等;《GenBank Database》;19960424;Accession No：AAA98115.1 *

Also Published As

Publication number Publication date
AU2016236297A1 (en) 2017-09-28
CA2979812C (en) 2023-08-29
EP3270950B1 (en) 2021-04-21
JP2018512844A (ja) 2018-05-24
JP6840086B2 (ja) 2021-03-10
AU2016236297B2 (en) 2020-07-23
CN107636011A (zh) 2018-01-26
EP3270950A1 (en) 2018-01-24
BR112017020008A2 (pt) 2018-06-19
CA2979812A1 (en) 2016-09-29
ES2880795T3 (es) 2021-11-25
US10323078B2 (en) 2019-06-18
DK3270950T3 (da) 2021-06-07
US20180105574A1 (en) 2018-04-19
WO2016150926A1 (en) 2016-09-29
BR112017020008A8 (pt) 2023-05-02

Similar Documents

Publication Publication Date Title
JP6981878B2 (ja) 抗菌療法
López-Expósito et al. Identification of antibacterial peptides from ovine αs2-casein
Li et al. OM‐LV20, a novel peptide from odorous frog skin, accelerates wound healing in vitro and in vivo
EP3010932B1 (en) Bacterial hyaluronidase and process for its production
Bolscher et al. A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin
Zhu et al. Identification and characterization of a C-type lectin in turbot (Scophthalmus maximus) which functioning as a pattern recognition receptor that binds and agglutinates various bacteria
Rotllant et al. Generation, purification and functional characterization of three C3a anaphylatoxins in rainbow trout: role in leukocyte chemotaxis and respiratory burst
CN107636011B (zh) 特别在皮肤炎性疾病中用作药物的来自血纤蛋白原的分离的肽及其片段
Lesiak et al. Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris
Kim et al. Antimicrobial activity of antimicrobial peptide LPcin-YK3 derived from bovine lactophoricin
Barberio et al. A low molecular weight protein with antimicrobial activity in the cutaneous ‘venom’of the yellow-bellied toad (Bombina variegata pachypus)
Rates et al. μ-Theraphotoxin-An1a: Primary structure determination and assessment of the pharmacological activity of a promiscuous anti-insect toxin from the venom of the tarantula Acanthoscurria natalensis (Mygalomorphae, Theraphosidae)
Ghorani-Azam et al. Effect of amino acid substitution on biological activity of cyanophlyctin-β and brevinin-2R
Sitaram et al. Seminalplasmin
CN105061575B (zh) 一种金枪鱼肝脏抗菌肽及其制备方法和用途
JP5101280B2 (ja) ヘルペスウイルス感染の治療のためのペプチド
Sarabia-Sainz et al. Bacterial recognition of thermal glycation products derived from porcine serum albumin with lactose
Jalaei et al. In vitro antihistamine-releasing activity of a peptide derived from wasp venom of Vespa orientalis
Brinkworth et al. Host defence peptides from the skin glands of Australian amphibians. Caerulein neuropeptides and antimicrobial, anticancer, and nNOS inhibiting citropins from the glandular frog Litoria subglandulosa
JPH03505449A (ja) 膜翅目昆虫毒、タンパク様あるいはポリペプチド成分、あるいはタンパク様あるいはポリペプチド成分のアナログを含む薬剤を用いた、哺乳類の感染症の処置に用いる方法および組成物
KR100849162B1 (ko) 세포 용혈활성이 감소된 항균 펩타이드
Moos et al. Purification and stability characterization of a cell regulatory sialoglgycopeptide inhibitor
Al-Khafaji The Effects of Extracted Peptide from Skin of Iraqi Frog (Rana ridibunda) on Human Leukemic Lymphocytes
Gaglione et al. Cryptic antimicrobial peptides hidden in protein precursors: Identification of novel bioactive molecules
Madzharova Characterization of the binding affinity and identification of potential inhibitors of type 3 fimbriae in Escherichia coli

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20211130

Address after: Paris France

Patentee after: UNIVERSITE PARIS DESCARTES

Patentee after: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

Patentee after: University of Paris Thackeray

Patentee after: University PIERRE ET MARIE CURIE (PARIS 6)

Patentee after: INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)

Patentee after: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

Patentee after: INST GUSTAVE-ROUSSY

Address before: Paris France

Patentee before: UNIVERSITE PARIS DESCARTES

Patentee before: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

Patentee before: UNIVERSITE PARIS-SUD 11

Patentee before: University PIERRE ET MARIE CURIE (PARIS 6)

Patentee before: INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)

Patentee before: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

Patentee before: INST GUSTAVE-ROUSSY

TR01 Transfer of patent right
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20220225

Address after: Paris France

Patentee after: UNIVERSITE PARIS DESCARTES

Patentee after: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

Patentee after: University of Paris Thackeray

Patentee after: SORBONNE UNIVERSITE

Patentee after: INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)

Patentee after: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

Patentee after: INST GUSTAVE-ROUSSY

Address before: Paris France

Patentee before: UNIVERSITE PARIS DESCARTES

Patentee before: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

Patentee before: University of Paris Thackeray

Patentee before: University PIERRE ET MARIE CURIE (PARIS 6)

Patentee before: INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)

Patentee before: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

Patentee before: INST GUSTAVE-ROUSSY

CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: Paris France

Patentee after: University of Western dais, Paris

Patentee after: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

Patentee after: University of Paris Thackeray

Patentee after: SORBONNE UNIVERSITE

Patentee after: INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)

Patentee after: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

Patentee after: INST GUSTAVE-ROUSSY

Address before: Paris France

Patentee before: University of Paris

Patentee before: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

Patentee before: University of Paris Thackeray

Patentee before: SORBONNE UNIVERSITE

Patentee before: INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)

Patentee before: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

Patentee before: INST GUSTAVE-ROUSSY

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20221230

Address after: Paris France

Patentee after: University of Paris

Patentee after: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

Patentee after: University of Paris Thackeray

Patentee after: SORBONNE UNIVERSITE

Patentee after: INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)

Patentee after: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

Patentee after: INST GUSTAVE-ROUSSY

Address before: Paris France

Patentee before: UNIVERSITE PARIS DESCARTES

Patentee before: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

Patentee before: University of Paris Thackeray

Patentee before: SORBONNE UNIVERSITE

Patentee before: INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)

Patentee before: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

Patentee before: INST GUSTAVE-ROUSSY